PMID- 32201298 OWN - NLM STAT- MEDLINE DCOM- 20210122 LR - 20210502 IS - 1873-5177 (Electronic) IS - 0091-3057 (Print) IS - 0091-3057 (Linking) VI - 192 DP - 2020 May TI - High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone. PG - 172912 LID - S0091-3057(19)30422-8 [pii] LID - 10.1016/j.pbb.2020.172912 [doi] AB - RATIONALE: Methylenedioxymethamphetamine (MDMA) and methcathinone (MCAT) are abused psychostimulant drugs that produce adverse effects in human users that include hepatotoxicity and death. Recent work has suggested a connection between hepatotoxicity, elevations in plasma ammonia, and brain glutamate function for methamphetamine (METH)-induced neurotoxicity. OBJECTIVES: These experiments investigated the effect of ambient temperature on the toxicity and lethality produced by MDMA and MCAT in mice, and whether these effects might involve similar mechanisms to those described for METH neurotoxicity. RESULTS: Under low (room temperature) ambient temperature conditions, MDMA induced hepatotoxicity, elevated plasma ammonia levels, and induced lethality. Under the same conditions, even a very high dose of MCAT produced limited toxic or lethal effects. High ambient temperature conditions potentiated the toxic and lethal effects of both MDMA and MCAT. CONCLUSION: These studies suggest that hepatotoxicity, plasma ammonia, and brain glutamate function are involved in MDMA-induced lethality, as has been shown for METH neurotoxicity. The toxicity and lethality of both MDMA and MCAT were potentiated by high ambient temperatures. Although an initial mouse study reported that several cathinones were much less toxic than METH or MDMA, the present results suggest that it will be essential to assess the potential dangers posed by these drugs under high ambient temperatures. CI - Copyright (c) 2020 Elsevier Inc. All rights reserved. FAU - Chen, Yu AU - Chen Y AD - Department of Pharmacology & Experimental Therapeutics, College of Pharmacology and Pharmacological Science, University of Toledo, OH, USA. FAU - Tran, Huyen T N AU - Tran HTN AD - Department of Pharmacology & Experimental Therapeutics, College of Pharmacology and Pharmacological Science, University of Toledo, OH, USA. FAU - Saber, Yasir H AU - Saber YH AD - Department of Pharmacology & Experimental Therapeutics, College of Pharmacology and Pharmacological Science, University of Toledo, OH, USA; Ninevah College of Medicine, Ninevah University, Mosul, Iraq. FAU - Hall, F Scott AU - Hall FS AD - Department of Pharmacology & Experimental Therapeutics, College of Pharmacology and Pharmacological Science, University of Toledo, OH, USA. Electronic address: frank.hall@utoledo.edu. LA - eng GR - R03 DA045350/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20200319 PL - United States TA - Pharmacol Biochem Behav JT - Pharmacology, biochemistry, and behavior JID - 0367050 RN - 0 (Central Nervous System Stimulants) RN - 0 (Propiophenones) RN - 386QA522QG (monomethylpropion) RN - 3KX376GY7L (Glutamic Acid) RN - 44RAL3456C (Methamphetamine) RN - 7664-41-7 (Ammonia) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Ammonia/blood MH - Animals MH - Brain/drug effects/metabolism MH - Central Nervous System Stimulants/*toxicity MH - Disease Models, Animal MH - Female MH - Glutamic Acid/metabolism MH - *Hot Temperature MH - Male MH - Methamphetamine/toxicity MH - Mice MH - Mice, Inbred C57BL MH - N-Methyl-3,4-methylenedioxyamphetamine/*toxicity MH - Neurotoxicity Syndromes/blood/*etiology/*mortality MH - Propiophenones/*toxicity MH - Signal Transduction/drug effects MH - Substance-Related Disorders/mortality PMC - PMC7294679 MID - NIHMS1579669 OTO - NOTNLM OT - Hepatotoxicity OT - Hyperthermia OT - Hypothermia OT - Lethality OT - Methcathinone OT - Methylenedioxymethamphetamine OT - Synthetic cathinones EDAT- 2020/03/24 06:00 MHDA- 2021/01/23 06:00 PMCR- 2021/05/01 CRDT- 2020/03/24 06:00 PHST- 2019/08/30 00:00 [received] PHST- 2020/03/12 00:00 [revised] PHST- 2020/03/19 00:00 [accepted] PHST- 2020/03/24 06:00 [pubmed] PHST- 2021/01/23 06:00 [medline] PHST- 2020/03/24 06:00 [entrez] PHST- 2021/05/01 00:00 [pmc-release] AID - S0091-3057(19)30422-8 [pii] AID - 10.1016/j.pbb.2020.172912 [doi] PST - ppublish SO - Pharmacol Biochem Behav. 2020 May;192:172912. doi: 10.1016/j.pbb.2020.172912. Epub 2020 Mar 19.